Coriell In The News
Dr. Michael Christman, Coriell's president and CEO, was recently consulted by a prominent national news source for his insights on direct-to-consumer genetic testing.
The 1000 Genomes Project, which houses its sample collection at Coriell Institute, has made inroads for human disease studies with a pair of papers published in Nature.
Dr. Dorit Berlin, Coriell's executive director of biobanking and scientific operations, was invited by the National Institutes of Health to participate in a two-day workshop broadcast to the research community.
Dr. Michael Christman discussed the promise of personalized medicine and its connection to several recent healthcare milestones in an interview with a business journal.
Coriell in headlines after announcing the availability of the world's largest stem cell collection.
Building on the success of a personalized medicine partnership formed in 2010, Coriell is enrolling an additional 4,500 Air Force participants into its innovative research study.
Dr. Michael Christman, Coriell's president and CEO, has been identified as one of South Jersey's most enterprising business figures.
Dr. David Pellman, chair of the CPMC research study's ICOB, publishes an influential scientific paper on genetic changes that occurs in cancer cells.
Coriell President and CEO Dr. Michael Christman was invited to lecture at the Festival of Genomics in Boston, a distinguished scientific conference.
A cell line from the NIGMS Repository at Coriell has yielded a DNA sample that can serve as an international research standard.
Giving to Coriell
As a non-profit institute, Coriell is fortunate to be engaged in several federally-funded awards. However, we rely on private philanthropy for our more cutting-edge, independent research. Thank you for supporting science!
Meet our Team
Click here to meet our leadership and scientific staff.